Home›People›Gregory Frost
Gregory Frost

Gregory Frost

Chairman & Chief Executive Officer at EXUMA Biotech.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Aug 20, 2026·Suggest an edit

About Gregory Frost

Gregory Frost is a chairman & chief executive officer at EXUMA Biotech.

Gregory Frost first appears on SEC filings in 2017.

Experience

This experience comes from Gregory Frost's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gregory Frost in the role, so the role may have started earlier or lasted longer.

EXUMA Biotechnology Current
Chairman & CEO
2015 – Present
F1 BioVentures Current
Managing Director
2015 – Present
EXUMA Biotech Corp.
Chairman & Chief Executive Officer
2017 – 2026 · West Palm Beach, FL
Develops cell and gene therapies for people with cancer and autoimmune diseases.
Intrexon Corporation
SVP Health Sector
2014 – 2015
Halozyme Therapeutics, Inc.
President and CEO
1999 – 2014
Sidney Kimmel Cancer Center
Sr Scientist
1997 – 2000

Key Colleagues at Startups

The people Gregory Frost works with at each company, as listed on that company's latest Form D.

EXUMA Biotech Corp. · Form D, Aug 20, 2026
David Ramsay
David Ramsay
Director
Richard Yan
Richard Yan
Vice President of Finance & Controller
Daniel Flynn
Daniel Flynn
Director

Sources

  1. SECEXUMA Biotech Corp. Form D, filed Aug 20, 2026